• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

venture capital

	Next higher product group	private equity

Record changed: 2019-10-10

Advertisement

More documents for venture capital

• [1] MiroBio Ltd.. (10/7/19). "Press Release: MiroBio Launches with £27m ($34m) Series A from Leading Life Sciences Investors". Oxford....
• [2] Aeovian Pharmaceuticals Inc.. (10/3/19). "Press Release: Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases". San Francisco, CA....
• [3] Arctoris Ltd.. (9/30/19). "Press Release: Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform Powered by Robotics". London....
• [4] Arix Bioscience plc. (9/30/19). "Press Release: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics". London....
• [5] T3 Pharmaceuticals AG. (9/26/19). "Press Release: Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic"....
• [6] Tacalyx GmbH. (9/25/19). "Press Release: Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment". Berlin....
• [7] Divide & Conquer. (9/18/19). "Press Release: Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature". Cambridge....
• [8] Versantis AG. (9/18/19). "Press Release: Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases". Zürich....
• [9] Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna....
• [10] UCL Technology Fund. (9/16/19). "Press Release: Echopoint Raises £2.8m to Address the ‘Grey Zone’ of Heart Disease treatment"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.